Parameter
| Biomarker | Urine IL-6、TGF-β1 | Full name | Urinary interleukin-6、Urinary transforming growth factor-beta 1 | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Disease progression prediction |
| Disease | Glomerulonephritis (GN) | Disease Subtypes | / | ||
| Organ | Kidney | Test Sample / Technology Platform | Urine | ||
| Pathobiological Mechanisms | Elevated levels of urinary IL-6 and TGF-β1 are associated with an increased risk of IgAN progression, and urinary IL-6 is an independent risk factor for IgAN progression. | ||||
| Clinical Availability Status | Research verification stage：The predictive value is clear and needs to be verified by clinical application. | ||||
| Notes and Dynamics | It provides an important basis for the prognostic stratification of IgAN and can guide the timing of clinical intervention. | ||||